Watch HEPA. Know when insiders buy.
One email the day a filing lands. Free.
HEPA
Hepion Pharmaceuticals, Inc.
0.18
+0.04 +28.57%
USD · close Oct 30
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
78
PASS · insiders 55, shorts 100
Insiders, 90 days
+$10K
net buying · 1 buy, 0 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $16.2MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$3.2MNET CASH $13.7M52W 0.04 – 0.18SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose HEPA in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
Gravitas Collective Corp.19.9%
“The Common Stock owned by the Reporting Person was acquired for investment purposes. The Reporting Person may make further acquisitions of the Common Stock from time to time. Except for the foregoing, the Reporting Person has no plans or proposals which relate to, or could result in, any of the matt…”
Kenneth Rickel7.2%
KI Holdings Ltd.10.2%
“The Reporting Person acquired the securities for investment purposes. The Reporting Person intends to review its investment in the Issuer on a continuing basis. Depending upon market conditions, the Issuer's business, financial condition, prospects, general economic conditions and other factors deem…”
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.